Scott M. Coiante

SVP, Chief Financial Officer at Lexicon Pharmaceuticals · 2 reported transactions in 1 company · latest report Feb 28, 2026

Their trades


Lexicon PharmaceuticalsLXRX	Shares withheld for tax $80.7K · 54,881 shares	Feb 28, 2026
Lexicon PharmaceuticalsLXRX	Exercised options — · 160,237 shares	Feb 28, 2026

Feb 28, 2026 · LXRX

$80.7K

Feb 28, 2026 · LXRX

160,237

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

SVP, Chief Financial Officer at Lexicon Pharmaceuticals · 2 reported transactions in 1 company · latest report Feb 28, 2026


Lexicon PharmaceuticalsLXRX	Shares withheld for tax $80.7K · 54,881 shares	Feb 28, 2026
Lexicon PharmaceuticalsLXRX	Exercised options — · 160,237 shares	Feb 28, 2026

Feb 28, 2026 · LXRX

$80.7K

Feb 28, 2026 · LXRX

160,237

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.